50 results
Page 2 of 3
8-K
EX-10.1
e9co1ce
4 Feb 21
Equillium Announces Pricing of $30 Million Registered Direct Offering
8:10am
424B5
xg7h5rac4zyn0
4 Feb 21
Prospectus supplement for primary offering
8:07am
8-K
0z2wl2yi83sz2xs
21 Dec 20
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of
8:06am
424B5
e3mrowgw6h81 gfcwn
14 Aug 20
Prospectus supplement for primary offering
4:45pm
424B5
yy0vq5h7pc7zvwoqwb
13 Aug 20
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
hwltndyp5zwgllvtb9r
13 May 20
Equillium Reports First Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
bt8h8rcsiz3gt
26 Mar 20
Equillium Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
0n9d3
12 Dec 19
Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to
7:05am
8-K
EX-99.2
fecd3ug3eh0 lmsjocdg
12 Nov 19
Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights
4:10pm
DEF 14A
4hea46nh3ih n9w
25 Apr 19
Definitive proxy
4:15pm